Medical Devices Industry Reports Urethral Stricture Treatment Market | Page 2

REPORT DESCRIPTION
Urethral Stricture Treatment Market – Overview
Urethral stricture is a medical condition, which causes narrowing of the urethra due to presence of a scar tissue, tissue
inflammation, infection or injury. This condition can cause obstructive dysfunction of urethra with potentially serious
consequences for the entire urinary tract. The urinary strictures are more common in males. They occur at any point
along the urethra, but are most often seen in the bulbar region and can range from less than 1cm long to the entire
length of the urethra. There are two types of urethral stricture conditions that occur in males, which include posterior
and anterior urethral strictures.
The cause of urethral stricture depends on the site of the stricture. Some of the common causes for this condition are
idiopathic, inflammatory (caused by infection or chronic inflammation in urethra, e.g., lichen sclerosus), traumatic
(caused due to injury to the urethra), iatrogenic (caused by medical intervention such as endoscopic procedures,
urethral catheterization, radiotherapy or surgery to neighboring organs), and congenital (caused by inherited conditions
such as hypospadias and epispadias).
Some of the common symptoms of urethral strictures includes painful urination, reduced urine output, incomplete
emptying of the bladder, and inability to void. There are various types of treatment available for urethral strictures
ranging from conservative or minimally invasive procedures to complex reconstructive procedures such as direct vision
internal urethrotomy (DVIU), urethroplasty, urethral dilation, and others.
© Coherent market Insights. All Rights Reserved